alpha-homonojirimycin,
homo-nojirimycin,
homonojirimycin,
alpha-Homonojirimycin,
Homonojirimycin,
119557-99-2,
a-Homonojirimycin,
alpha-Homoallonojirimycin,
(2r,3r,5s,6r)-2,6-bis(hydroxymethyl)piperidine-3,4,5-triol,
CHEMBL501355,
CHEMBL2111688,
Hnj cpd,
.alpha.-Homonojirimycin,
2,6-Bis-hydroxymethyl-piperidine-3,4,5-triol,
AC1L4LY0,
AC1Q59RO,
3,4,5-Piperidinetriol,2,6-bis(hydroxymethyl)-, (2R,3R,5S,6R)-,
SCHEMBL1469250,
SCHEMBL2265529,
SCHEMBL2265531,
BDBM18366,
CTK4B1372,
CLVUFWXGNIFGNC-OVHBTUCOSA-N,
CLVUFWXGNIFGNC-QTSLKERKSA-N,
alpha-homonojirimycin (alpha-HNJ),
BDBM50259956,
BDBM50403720,
MFCD06797112,
ZINC100052912,
alpha-Homonojirimycin, >=98.0% (TLC),
W-200929,
I14-58129,
5F014EC3-E03F-4855-8605-373D1AF7D2CA,
(2R,3S,5R,6R)-2,6-bis(hydroxymethyl)piperidine-3,4,5-triol,
|A-Homonojirimycin,
D03TYC,
KST-1A1309,
KST-1A1311,
AR-1A2907,
AR-1A2908,
CID159496,
H1144,
140196-60-7,
14022-19-6,